0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intracranial Drug Eluting Stents Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-24G9384
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Intracranial Drug Eluting Stents Market Research Report 2022
BUY CHAPTERS

Global Intracranial Drug Eluting Stents Market Research Report 2024

Code: QYRE-Auto-24G9384
Report
March 2024
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Intracranial Drug Eluting Stents Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Intracranial Drug Eluting Stents Market

Intracranial Drug Eluting Stents Market

The global Intracranial Drug Eluting Stents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intracranial Drug Eluting Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intracranial Drug Eluting Stents.

Report Scope

The Intracranial Drug Eluting Stents market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intracranial Drug Eluting Stents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intracranial Drug Eluting Stents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Intracranial Drug Eluting Stents Market Report

Report Metric Details
Report Name Intracranial Drug Eluting Stents Market
CAGR 5%
Segment by Type
  • Cobalt-chromium Alloy Stents
  • Magnesium Alloy Stents
  • Stainless Steel Stents
  • Others
Segment by Application
  • Hospital
  • Specialty Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Medtronic Vascular, Advantec Vascular, B.Braun Melsengen, Boston Scientific, Terumo Medical, Biosensors, Biotronik, Blue Medical, DISA Vascular, Essen, MicroPort Medical, MIV Therapeutics, Orbusneich, Promed Medical, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin, TEDA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intracranial Drug Eluting Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intracranial Drug Eluting Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Intracranial Drug Eluting Stents Market report?

Ans: The main players in the Intracranial Drug Eluting Stents Market are Abbott, Medtronic Vascular, Advantec Vascular, B.Braun Melsengen, Boston Scientific, Terumo Medical, Biosensors, Biotronik, Blue Medical, DISA Vascular, Essen, MicroPort Medical, MIV Therapeutics, Orbusneich, Promed Medical, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin, TEDA

What are the Application segmentation covered in the Intracranial Drug Eluting Stents Market report?

Ans: The Applications covered in the Intracranial Drug Eluting Stents Market report are Hospital, Specialty Clinic, Others

What are the Type segmentation covered in the Intracranial Drug Eluting Stents Market report?

Ans: The Types covered in the Intracranial Drug Eluting Stents Market report are Cobalt-chromium Alloy Stents, Magnesium Alloy Stents, Stainless Steel Stents, Others

1 Intracranial Drug Eluting Stents Market Overview
1.1 Product Overview and Scope of Intracranial Drug Eluting Stents
1.2 Intracranial Drug Eluting Stents Segment by Type
1.2.1 Global Intracranial Drug Eluting Stents Market Value Comparison by Type (2024-2030)
1.2.2 Cobalt-chromium Alloy Stents
1.2.3 Magnesium Alloy Stents
1.2.4 Stainless Steel Stents
1.2.5 Others
1.3 Intracranial Drug Eluting Stents Segment by Application
1.3.1 Global Intracranial Drug Eluting Stents Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Global Intracranial Drug Eluting Stents Market Size Estimates and Forecasts
1.4.1 Global Intracranial Drug Eluting Stents Revenue 2019-2030
1.4.2 Global Intracranial Drug Eluting Stents Sales 2019-2030
1.4.3 Global Intracranial Drug Eluting Stents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intracranial Drug Eluting Stents Market Competition by Manufacturers
2.1 Global Intracranial Drug Eluting Stents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intracranial Drug Eluting Stents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intracranial Drug Eluting Stents Average Price by Manufacturers (2019-2024)
2.4 Global Intracranial Drug Eluting Stents Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intracranial Drug Eluting Stents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intracranial Drug Eluting Stents, Product Type & Application
2.7 Intracranial Drug Eluting Stents Market Competitive Situation and Trends
2.7.1 Intracranial Drug Eluting Stents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intracranial Drug Eluting Stents Players Market Share by Revenue
2.7.3 Global Intracranial Drug Eluting Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intracranial Drug Eluting Stents Retrospective Market Scenario by Region
3.1 Global Intracranial Drug Eluting Stents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intracranial Drug Eluting Stents Global Intracranial Drug Eluting Stents Sales by Region: 2019-2030
3.2.1 Global Intracranial Drug Eluting Stents Sales by Region: 2019-2024
3.2.2 Global Intracranial Drug Eluting Stents Sales by Region: 2025-2030
3.3 Global Intracranial Drug Eluting Stents Global Intracranial Drug Eluting Stents Revenue by Region: 2019-2030
3.3.1 Global Intracranial Drug Eluting Stents Revenue by Region: 2019-2024
3.3.2 Global Intracranial Drug Eluting Stents Revenue by Region: 2025-2030
3.4 North America Intracranial Drug Eluting Stents Market Facts & Figures by Country
3.4.1 North America Intracranial Drug Eluting Stents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intracranial Drug Eluting Stents Sales by Country (2019-2030)
3.4.3 North America Intracranial Drug Eluting Stents Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intracranial Drug Eluting Stents Market Facts & Figures by Country
3.5.1 Europe Intracranial Drug Eluting Stents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intracranial Drug Eluting Stents Sales by Country (2019-2030)
3.5.3 Europe Intracranial Drug Eluting Stents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intracranial Drug Eluting Stents Market Facts & Figures by Country
3.6.1 Asia Pacific Intracranial Drug Eluting Stents Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intracranial Drug Eluting Stents Sales by Country (2019-2030)
3.6.3 Asia Pacific Intracranial Drug Eluting Stents Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intracranial Drug Eluting Stents Market Facts & Figures by Country
3.7.1 Latin America Intracranial Drug Eluting Stents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intracranial Drug Eluting Stents Sales by Country (2019-2030)
3.7.3 Latin America Intracranial Drug Eluting Stents Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intracranial Drug Eluting Stents Market Facts & Figures by Country
3.8.1 Middle East and Africa Intracranial Drug Eluting Stents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intracranial Drug Eluting Stents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intracranial Drug Eluting Stents Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intracranial Drug Eluting Stents Sales by Type (2019-2030)
4.1.1 Global Intracranial Drug Eluting Stents Sales by Type (2019-2024)
4.1.2 Global Intracranial Drug Eluting Stents Sales by Type (2025-2030)
4.1.3 Global Intracranial Drug Eluting Stents Sales Market Share by Type (2019-2030)
4.2 Global Intracranial Drug Eluting Stents Revenue by Type (2019-2030)
4.2.1 Global Intracranial Drug Eluting Stents Revenue by Type (2019-2024)
4.2.2 Global Intracranial Drug Eluting Stents Revenue by Type (2025-2030)
4.2.3 Global Intracranial Drug Eluting Stents Revenue Market Share by Type (2019-2030)
4.3 Global Intracranial Drug Eluting Stents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intracranial Drug Eluting Stents Sales by Application (2019-2030)
5.1.1 Global Intracranial Drug Eluting Stents Sales by Application (2019-2024)
5.1.2 Global Intracranial Drug Eluting Stents Sales by Application (2025-2030)
5.1.3 Global Intracranial Drug Eluting Stents Sales Market Share by Application (2019-2030)
5.2 Global Intracranial Drug Eluting Stents Revenue by Application (2019-2030)
5.2.1 Global Intracranial Drug Eluting Stents Revenue by Application (2019-2024)
5.2.2 Global Intracranial Drug Eluting Stents Revenue by Application (2025-2030)
5.2.3 Global Intracranial Drug Eluting Stents Revenue Market Share by Application (2019-2030)
5.3 Global Intracranial Drug Eluting Stents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Intracranial Drug Eluting Stents Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Medtronic Vascular
6.2.1 Medtronic Vascular Corporation Information
6.2.2 Medtronic Vascular Description and Business Overview
6.2.3 Medtronic Vascular Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Vascular Intracranial Drug Eluting Stents Product Portfolio
6.2.5 Medtronic Vascular Recent Developments/Updates
6.3 Advantec Vascular
6.3.1 Advantec Vascular Corporation Information
6.3.2 Advantec Vascular Description and Business Overview
6.3.3 Advantec Vascular Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Advantec Vascular Intracranial Drug Eluting Stents Product Portfolio
6.3.5 Advantec Vascular Recent Developments/Updates
6.4 B.Braun Melsengen
6.4.1 B.Braun Melsengen Corporation Information
6.4.2 B.Braun Melsengen Description and Business Overview
6.4.3 B.Braun Melsengen Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 B.Braun Melsengen Intracranial Drug Eluting Stents Product Portfolio
6.4.5 B.Braun Melsengen Recent Developments/Updates
6.5 Boston Scientific
6.5.1 Boston Scientific Corporation Information
6.5.2 Boston Scientific Description and Business Overview
6.5.3 Boston Scientific Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boston Scientific Intracranial Drug Eluting Stents Product Portfolio
6.5.5 Boston Scientific Recent Developments/Updates
6.6 Terumo Medical
6.6.1 Terumo Medical Corporation Information
6.6.2 Terumo Medical Description and Business Overview
6.6.3 Terumo Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Terumo Medical Intracranial Drug Eluting Stents Product Portfolio
6.6.5 Terumo Medical Recent Developments/Updates
6.7 Biosensors
6.6.1 Biosensors Corporation Information
6.6.2 Biosensors Description and Business Overview
6.6.3 Biosensors Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biosensors Intracranial Drug Eluting Stents Product Portfolio
6.7.5 Biosensors Recent Developments/Updates
6.8 Biotronik
6.8.1 Biotronik Corporation Information
6.8.2 Biotronik Description and Business Overview
6.8.3 Biotronik Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biotronik Intracranial Drug Eluting Stents Product Portfolio
6.8.5 Biotronik Recent Developments/Updates
6.9 Blue Medical
6.9.1 Blue Medical Corporation Information
6.9.2 Blue Medical Description and Business Overview
6.9.3 Blue Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Blue Medical Intracranial Drug Eluting Stents Product Portfolio
6.9.5 Blue Medical Recent Developments/Updates
6.10 DISA Vascular
6.10.1 DISA Vascular Corporation Information
6.10.2 DISA Vascular Description and Business Overview
6.10.3 DISA Vascular Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.10.4 DISA Vascular Intracranial Drug Eluting Stents Product Portfolio
6.10.5 DISA Vascular Recent Developments/Updates
6.11 Essen
6.11.1 Essen Corporation Information
6.11.2 Essen Intracranial Drug Eluting Stents Description and Business Overview
6.11.3 Essen Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Essen Intracranial Drug Eluting Stents Product Portfolio
6.11.5 Essen Recent Developments/Updates
6.12 MicroPort Medical
6.12.1 MicroPort Medical Corporation Information
6.12.2 MicroPort Medical Intracranial Drug Eluting Stents Description and Business Overview
6.12.3 MicroPort Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.12.4 MicroPort Medical Intracranial Drug Eluting Stents Product Portfolio
6.12.5 MicroPort Medical Recent Developments/Updates
6.13 MIV Therapeutics
6.13.1 MIV Therapeutics Corporation Information
6.13.2 MIV Therapeutics Intracranial Drug Eluting Stents Description and Business Overview
6.13.3 MIV Therapeutics Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.13.4 MIV Therapeutics Intracranial Drug Eluting Stents Product Portfolio
6.13.5 MIV Therapeutics Recent Developments/Updates
6.14 Orbusneich
6.14.1 Orbusneich Corporation Information
6.14.2 Orbusneich Intracranial Drug Eluting Stents Description and Business Overview
6.14.3 Orbusneich Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Orbusneich Intracranial Drug Eluting Stents Product Portfolio
6.14.5 Orbusneich Recent Developments/Updates
6.15 Promed Medical
6.15.1 Promed Medical Corporation Information
6.15.2 Promed Medical Intracranial Drug Eluting Stents Description and Business Overview
6.15.3 Promed Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Promed Medical Intracranial Drug Eluting Stents Product Portfolio
6.15.5 Promed Medical Recent Developments/Updates
6.16 Relisys Medical
6.16.1 Relisys Medical Corporation Information
6.16.2 Relisys Medical Intracranial Drug Eluting Stents Description and Business Overview
6.16.3 Relisys Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Relisys Medical Intracranial Drug Eluting Stents Product Portfolio
6.16.5 Relisys Medical Recent Developments/Updates
6.17 Reva Medical
6.17.1 Reva Medical Corporation Information
6.17.2 Reva Medical Intracranial Drug Eluting Stents Description and Business Overview
6.17.3 Reva Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Reva Medical Intracranial Drug Eluting Stents Product Portfolio
6.17.5 Reva Medical Recent Developments/Updates
6.18 Sahajanand
6.18.1 Sahajanand Corporation Information
6.18.2 Sahajanand Intracranial Drug Eluting Stents Description and Business Overview
6.18.3 Sahajanand Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Sahajanand Intracranial Drug Eluting Stents Product Portfolio
6.18.5 Sahajanand Recent Developments/Updates
6.19 Sino Medical
6.19.1 Sino Medical Corporation Information
6.19.2 Sino Medical Intracranial Drug Eluting Stents Description and Business Overview
6.19.3 Sino Medical Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Sino Medical Intracranial Drug Eluting Stents Product Portfolio
6.19.5 Sino Medical Recent Developments/Updates
6.20 Sorin
6.20.1 Sorin Corporation Information
6.20.2 Sorin Intracranial Drug Eluting Stents Description and Business Overview
6.20.3 Sorin Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Sorin Intracranial Drug Eluting Stents Product Portfolio
6.20.5 Sorin Recent Developments/Updates
6.21 TEDA
6.21.1 TEDA Corporation Information
6.21.2 TEDA Intracranial Drug Eluting Stents Description and Business Overview
6.21.3 TEDA Intracranial Drug Eluting Stents Sales, Revenue and Gross Margin (2019-2024)
6.21.4 TEDA Intracranial Drug Eluting Stents Product Portfolio
6.21.5 TEDA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intracranial Drug Eluting Stents Industry Chain Analysis
7.2 Intracranial Drug Eluting Stents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intracranial Drug Eluting Stents Production Mode & Process
7.4 Intracranial Drug Eluting Stents Sales and Marketing
7.4.1 Intracranial Drug Eluting Stents Sales Channels
7.4.2 Intracranial Drug Eluting Stents Distributors
7.5 Intracranial Drug Eluting Stents Customers
8 Intracranial Drug Eluting Stents Market Dynamics
8.1 Intracranial Drug Eluting Stents Industry Trends
8.2 Intracranial Drug Eluting Stents Market Drivers
8.3 Intracranial Drug Eluting Stents Market Challenges
8.4 Intracranial Drug Eluting Stents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Intracranial Drug Eluting Stents Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Intracranial Drug Eluting Stents Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Intracranial Drug Eluting Stents Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Intracranial Drug Eluting Stents Sales (Units) of Key Manufacturers (2019-2024)
    Table 5. Global Intracranial Drug Eluting Stents Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Intracranial Drug Eluting Stents Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Intracranial Drug Eluting Stents Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Intracranial Drug Eluting Stents Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Intracranial Drug Eluting Stents, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Intracranial Drug Eluting Stents, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Intracranial Drug Eluting Stents, Product Type & Application
    Table 12. Global Key Manufacturers of Intracranial Drug Eluting Stents, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Intracranial Drug Eluting Stents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intracranial Drug Eluting Stents as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Intracranial Drug Eluting Stents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Intracranial Drug Eluting Stents Sales by Region (2019-2024) & (Units)
    Table 18. Global Intracranial Drug Eluting Stents Sales Market Share by Region (2019-2024)
    Table 19. Global Intracranial Drug Eluting Stents Sales by Region (2025-2030) & (Units)
    Table 20. Global Intracranial Drug Eluting Stents Sales Market Share by Region (2025-2030)
    Table 21. Global Intracranial Drug Eluting Stents Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Intracranial Drug Eluting Stents Revenue Market Share by Region (2019-2024)
    Table 23. Global Intracranial Drug Eluting Stents Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Intracranial Drug Eluting Stents Revenue Market Share by Region (2025-2030)
    Table 25. North America Intracranial Drug Eluting Stents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Intracranial Drug Eluting Stents Sales by Country (2019-2024) & (Units)
    Table 27. North America Intracranial Drug Eluting Stents Sales by Country (2025-2030) & (Units)
    Table 28. North America Intracranial Drug Eluting Stents Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Intracranial Drug Eluting Stents Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Intracranial Drug Eluting Stents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Intracranial Drug Eluting Stents Sales by Country (2019-2024) & (Units)
    Table 32. Europe Intracranial Drug Eluting Stents Sales by Country (2025-2030) & (Units)
    Table 33. Europe Intracranial Drug Eluting Stents Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Intracranial Drug Eluting Stents Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Intracranial Drug Eluting Stents Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Intracranial Drug Eluting Stents Sales by Region (2019-2024) & (Units)
    Table 37. Asia Pacific Intracranial Drug Eluting Stents Sales by Region (2025-2030) & (Units)
    Table 38. Asia Pacific Intracranial Drug Eluting Stents Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Intracranial Drug Eluting Stents Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Intracranial Drug Eluting Stents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Intracranial Drug Eluting Stents Sales by Country (2019-2024) & (Units)
    Table 42. Latin America Intracranial Drug Eluting Stents Sales by Country (2025-2030) & (Units)
    Table 43. Latin America Intracranial Drug Eluting Stents Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Intracranial Drug Eluting Stents Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Intracranial Drug Eluting Stents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Intracranial Drug Eluting Stents Sales by Country (2019-2024) & (Units)
    Table 47. Middle East & Africa Intracranial Drug Eluting Stents Sales by Country (2025-2030) & (Units)
    Table 48. Middle East & Africa Intracranial Drug Eluting Stents Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Intracranial Drug Eluting Stents Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Intracranial Drug Eluting Stents Sales (Units) by Type (2019-2024)
    Table 51. Global Intracranial Drug Eluting Stents Sales (Units) by Type (2025-2030)
    Table 52. Global Intracranial Drug Eluting Stents Sales Market Share by Type (2019-2024)
    Table 53. Global Intracranial Drug Eluting Stents Sales Market Share by Type (2025-2030)
    Table 54. Global Intracranial Drug Eluting Stents Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Intracranial Drug Eluting Stents Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Intracranial Drug Eluting Stents Revenue Market Share by Type (2019-2024)
    Table 57. Global Intracranial Drug Eluting Stents Revenue Market Share by Type (2025-2030)
    Table 58. Global Intracranial Drug Eluting Stents Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Intracranial Drug Eluting Stents Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Intracranial Drug Eluting Stents Sales (Units) by Application (2019-2024)
    Table 61. Global Intracranial Drug Eluting Stents Sales (Units) by Application (2025-2030)
    Table 62. Global Intracranial Drug Eluting Stents Sales Market Share by Application (2019-2024)
    Table 63. Global Intracranial Drug Eluting Stents Sales Market Share by Application (2025-2030)
    Table 64. Global Intracranial Drug Eluting Stents Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Intracranial Drug Eluting Stents Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Intracranial Drug Eluting Stents Revenue Market Share by Application (2019-2024)
    Table 67. Global Intracranial Drug Eluting Stents Revenue Market Share by Application (2025-2030)
    Table 68. Global Intracranial Drug Eluting Stents Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Intracranial Drug Eluting Stents Price (US$/Unit) by Application (2025-2030)
    Table 70. Abbott Corporation Information
    Table 71. Abbott Description and Business Overview
    Table 72. Abbott Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Abbott Intracranial Drug Eluting Stents Product
    Table 74. Abbott Recent Developments/Updates
    Table 75. Medtronic Vascular Corporation Information
    Table 76. Medtronic Vascular Description and Business Overview
    Table 77. Medtronic Vascular Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Medtronic Vascular Intracranial Drug Eluting Stents Product
    Table 79. Medtronic Vascular Recent Developments/Updates
    Table 80. Advantec Vascular Corporation Information
    Table 81. Advantec Vascular Description and Business Overview
    Table 82. Advantec Vascular Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Advantec Vascular Intracranial Drug Eluting Stents Product
    Table 84. Advantec Vascular Recent Developments/Updates
    Table 85. B.Braun Melsengen Corporation Information
    Table 86. B.Braun Melsengen Description and Business Overview
    Table 87. B.Braun Melsengen Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. B.Braun Melsengen Intracranial Drug Eluting Stents Product
    Table 89. B.Braun Melsengen Recent Developments/Updates
    Table 90. Boston Scientific Corporation Information
    Table 91. Boston Scientific Description and Business Overview
    Table 92. Boston Scientific Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Boston Scientific Intracranial Drug Eluting Stents Product
    Table 94. Boston Scientific Recent Developments/Updates
    Table 95. Terumo Medical Corporation Information
    Table 96. Terumo Medical Description and Business Overview
    Table 97. Terumo Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Terumo Medical Intracranial Drug Eluting Stents Product
    Table 99. Terumo Medical Recent Developments/Updates
    Table 100. Biosensors Corporation Information
    Table 101. Biosensors Description and Business Overview
    Table 102. Biosensors Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Biosensors Intracranial Drug Eluting Stents Product
    Table 104. Biosensors Recent Developments/Updates
    Table 105. Biotronik Corporation Information
    Table 106. Biotronik Description and Business Overview
    Table 107. Biotronik Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Biotronik Intracranial Drug Eluting Stents Product
    Table 109. Biotronik Recent Developments/Updates
    Table 110. Blue Medical Corporation Information
    Table 111. Blue Medical Description and Business Overview
    Table 112. Blue Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Blue Medical Intracranial Drug Eluting Stents Product
    Table 114. Blue Medical Recent Developments/Updates
    Table 115. DISA Vascular Corporation Information
    Table 116. DISA Vascular Description and Business Overview
    Table 117. DISA Vascular Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. DISA Vascular Intracranial Drug Eluting Stents Product
    Table 119. DISA Vascular Recent Developments/Updates
    Table 120. Essen Corporation Information
    Table 121. Essen Description and Business Overview
    Table 122. Essen Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Essen Intracranial Drug Eluting Stents Product
    Table 124. Essen Recent Developments/Updates
    Table 125. MicroPort Medical Corporation Information
    Table 126. MicroPort Medical Description and Business Overview
    Table 127. MicroPort Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. MicroPort Medical Intracranial Drug Eluting Stents Product
    Table 129. MicroPort Medical Recent Developments/Updates
    Table 130. MIV Therapeutics Corporation Information
    Table 131. MIV Therapeutics Description and Business Overview
    Table 132. MIV Therapeutics Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. MIV Therapeutics Intracranial Drug Eluting Stents Product
    Table 134. MIV Therapeutics Recent Developments/Updates
    Table 135. Orbusneich Corporation Information
    Table 136. Orbusneich Description and Business Overview
    Table 137. Orbusneich Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Orbusneich Intracranial Drug Eluting Stents Product
    Table 139. Orbusneich Recent Developments/Updates
    Table 140. Promed Medical Corporation Information
    Table 141. Promed Medical Description and Business Overview
    Table 142. Promed Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. Promed Medical Intracranial Drug Eluting Stents Product
    Table 144. Promed Medical Recent Developments/Updates
    Table 145. Relisys Medical Corporation Information
    Table 146. Relisys Medical Description and Business Overview
    Table 147. Relisys Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 148. Relisys Medical Intracranial Drug Eluting Stents Product
    Table 149. Relisys Medical Recent Developments/Updates
    Table 150. Reva Medical Corporation Information
    Table 151. Reva Medical Description and Business Overview
    Table 152. Reva Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 153. Reva Medical Intracranial Drug Eluting Stents Product
    Table 154. Reva Medical Recent Developments/Updates
    Table 155. Sahajanand Corporation Information
    Table 156. Sahajanand Description and Business Overview
    Table 157. Sahajanand Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 158. Sahajanand Intracranial Drug Eluting Stents Product
    Table 159. Sahajanand Recent Developments/Updates
    Table 160. Sino Medical Corporation Information
    Table 161. Sino Medical Description and Business Overview
    Table 162. Sino Medical Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 163. Sino Medical Intracranial Drug Eluting Stents Product
    Table 164. Sino Medical Recent Developments/Updates
    Table 165. Sorin Corporation Information
    Table 166. Sorin Description and Business Overview
    Table 167. Sorin Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 168. Sorin Intracranial Drug Eluting Stents Product
    Table 169. Sorin Recent Developments/Updates
    Table 170. TEDA Corporation Information
    Table 171. TEDA Description and Business Overview
    Table 172. TEDA Intracranial Drug Eluting Stents Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 173. TEDA Intracranial Drug Eluting Stents Product
    Table 174. TEDA Recent Developments/Updates
    Table 175. Key Raw Materials Lists
    Table 176. Raw Materials Key Suppliers Lists
    Table 177. Intracranial Drug Eluting Stents Distributors List
    Table 178. Intracranial Drug Eluting Stents Customers List
    Table 179. Intracranial Drug Eluting Stents Market Trends
    Table 180. Intracranial Drug Eluting Stents Market Drivers
    Table 181. Intracranial Drug Eluting Stents Market Challenges
    Table 182. Intracranial Drug Eluting Stents Market Restraints
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Intracranial Drug Eluting Stents
    Figure 2. Global Intracranial Drug Eluting Stents Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Intracranial Drug Eluting Stents Market Share by Type in 2023 & 2030
    Figure 4. Cobalt-chromium Alloy Stents Product Picture
    Figure 5. Magnesium Alloy Stents Product Picture
    Figure 6. Stainless Steel Stents Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Intracranial Drug Eluting Stents Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Intracranial Drug Eluting Stents Market Share by Application in 2023 & 2030
    Figure 10. Hospital
    Figure 11. Specialty Clinic
    Figure 12. Others
    Figure 13. Global Intracranial Drug Eluting Stents Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Intracranial Drug Eluting Stents Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Intracranial Drug Eluting Stents Sales (2019-2030) & (Units)
    Figure 16. Global Intracranial Drug Eluting Stents Average Price (US$/Unit) & (2019-2030)
    Figure 17. Intracranial Drug Eluting Stents Report Years Considered
    Figure 18. Intracranial Drug Eluting Stents Sales Share by Manufacturers in 2023
    Figure 19. Global Intracranial Drug Eluting Stents Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Intracranial Drug Eluting Stents Players: Market Share by Revenue in 2023
    Figure 21. Intracranial Drug Eluting Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Intracranial Drug Eluting Stents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Intracranial Drug Eluting Stents Sales Market Share by Country (2019-2030)
    Figure 24. North America Intracranial Drug Eluting Stents Revenue Market Share by Country (2019-2030)
    Figure 25. U.S. Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Intracranial Drug Eluting Stents Sales Market Share by Country (2019-2030)
    Figure 28. Europe Intracranial Drug Eluting Stents Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Intracranial Drug Eluting Stents Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Intracranial Drug Eluting Stents Revenue Market Share by Region (2019-2030)
    Figure 36. China Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Taiwan Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Philippines Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Latin America Intracranial Drug Eluting Stents Sales Market Share by Country (2019-2030)
    Figure 47. Latin America Intracranial Drug Eluting Stents Revenue Market Share by Country (2019-2030)
    Figure 48. Mexico Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Brazil Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Argentina Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Middle East & Africa Intracranial Drug Eluting Stents Sales Market Share by Country (2019-2030)
    Figure 52. Middle East & Africa Intracranial Drug Eluting Stents Revenue Market Share by Country (2019-2030)
    Figure 53. Turkey Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. U.A.E Intracranial Drug Eluting Stents Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Global Sales Market Share of Intracranial Drug Eluting Stents by Type (2019-2030)
    Figure 57. Global Revenue Market Share of Intracranial Drug Eluting Stents by Type (2019-2030)
    Figure 58. Global Intracranial Drug Eluting Stents Price (US$/Unit) by Type (2019-2030)
    Figure 59. Global Sales Market Share of Intracranial Drug Eluting Stents by Application (2019-2030)
    Figure 60. Global Revenue Market Share of Intracranial Drug Eluting Stents by Application (2019-2030)
    Figure 61. Global Intracranial Drug Eluting Stents Price (US$/Unit) by Application (2019-2030)
    Figure 62. Intracranial Drug Eluting Stents Value Chain
    Figure 63. Intracranial Drug Eluting Stents Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Dual Chamber Temporary Pacemaker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-35Y14435
Tue Nov 12 00:00:00 UTC 2024

Add to Cart

Hemodynamic Altering Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-36L13936
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Heart Valve Repair Products - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-0F18702
Tue Oct 22 00:00:00 UTC 2024

Add to Cart

Add to Cart